Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
CNY 4.03
(-0.74%)
CNY 4.03
(-0.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 125.76 Million | 502.15 Million | 324.92 Million | 231.77 Million | 467.41 Million | -157.44 Million |
| Net Income | -412.46 Million | 135.97 Million | 116.68 Million | 153.72 Million | 293.18 Million | 571.76 Million |
| Depreciation & Amortization | 116.65 Million | 116.16 Million | 107.01 Million | 96.48 Million | 88.6 Million | 80.14 Million |
| Deferred income taxes | -111.49 Million | -12.45 Million | -3.09 Million | -15.05 Million | -4.95 Million | -8.95 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 191.61 Million | 33.49 Million | 17.49 Million | -237.05 Million | -125.31 Million | -870.78 Million |
| Other non-cash items | 94.43 Million | 216.52 Million | 83.72 Million | 218.62 Million | 210.93 Million | 61.43 Million |
| Investing Cash Flow | -34.83 Million | 20.43 Million | 42.58 Million | -204.74 Million | -534.5 Million | -859.26 Million |
| Investments in PPE | -104.11 Million | -68.45 Million | -425.72 Million | -90.02 Million | -121.9 Million | -129.01 Million |
| Acquisitions | -3.91 Million | - | 123.29 Thousand | -31.39 Million | - | 129.23 Million |
| Investment purchases | - | -14.7 Million | -86 Million | 153.34 Thousand | -465.11 Million | -732.59 Million |
| Sales/Maturities of investments | 25.04 Million | 61.97 Million | 17.8 Million | 12.21 Million | 329.74 Thousand | 2.11 Million |
| Other Investing Activities | 46.7 Million | 41.61 Million | 536.38 Million | -95.68 Million | 52.19 Million | -129.01 Million |
| Financing Cash Flow | -214.8 Million | -315.27 Million | -766.39 Million | -411.36 Million | 624.2 Million | 562.11 Million |
| Debt repayment | -15.98 Million | -1.66 Billion | -2.18 Billion | -2.36 Billion | -1.58 Billion | -861.6 Million |
| Dividends payments | -80.54 Million | -86.55 Million | -100.18 Million | -310.46 Million | -112.89 Million | -157.88 Million |
| Common Stock Repurchased | -100 Million | - | -100.2 Million | - | - | - |
| Common Stock Issuance | - | - | 100.2 Million | - | - | - |
| Other Financing Activities | -150.24 Million | 1.43 Billion | 1.51 Billion | 2.38 Billion | 2.42 Billion | 1.58 Billion |
| Accounts receivables | -34.96 Million | -182.7 Million | 193.72 Million | -163.73 Million | 145.33 Million | -829.23 Million |
| Accounts payables | 734.65 Million | 219.92 Million | -95.76 Million | 33.3 Million | -111.93 Million | -8.53 Million |
| Inventory | -396.57 Million | 8.73 Million | -63.22 Million | 221.06 Million | -146.08 Million | -24.05 Million |
| Other working capital | 623.15 Million | -12.45 Million | -17.23 Million | -327.68 Million | -12.62 Million | -846.73 Million |
| Cash at beginning of period | 526.75 Million | 319.44 Million | 718.33 Million | 1.1 Billion | 545.54 Million | 1 Billion |
| Cash at end of period | 402.88 Million | 526.75 Million | 319.44 Million | 718.33 Million | 1.1 Billion | 545.54 Million |
| Capital Expenditure | -104.11 Million | -68.45 Million | -425.72 Million | -90.02 Million | -121.9 Million | -129.01 Million |
| Effect of forex changes on cash | -7.82 | 11.09 | -19.87 | 0.70 | -5078.19 | 0.85 |
| Net cash flow / Change in cash | -123.87 Million | 207.31 Million | -398.88 Million | -384.33 Million | 557.11 Million | -454.59 Million |
| Free Cash Flow | 21.64 Million | 433.7 Million | -100.8 Million | 141.75 Million | 345.5 Million | -286.45 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 754.62 Thousand | 35.76 Million | 51.69 Million | -412.46 Million | -554.99 Million | 20.14 Million |
| Depreciation & Amortization | - | 31.37 Million | 31.37 Million | 116.65 Million | 116.65 Million | -55.96 Million |
| Deferred income taxes | - | - | - | -111.49 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -337.05 Million | - | 191.61 Million | -431.54 Million | 283.13 Million |
| Other non-cash items | -13.69 Million | 215.31 Million | -306.35 Million | 94.43 Million | 1.07 Billion | -439.65 Million |
| Investing Cash Flow | -87.3 Million | 17.41 Million | -13.59 Million | -34.83 Million | 54.14 Million | -18.47 Million |
| Investments in PPE | -76.71 Million | 11.21 Million | -18.18 Million | -104.11 Million | 30.63 Million | -23.36 Million |
| Acquisitions | 9620.00 | 13 Thousand | - | -3.91 Million | -3.91 Million | 11.8 Thousand |
| Investment purchases | - | - | - | - | 4.29 Million | -11.79 Thousand |
| Sales/Maturities of investments | - | 9.18 Million | 4.58 Million | 25.04 Million | 18.86 Million | 4.88 Million |
| Other Investing Activities | -10.59 Million | -3 Million | 4.58 Million | 46.7 Million | 2.82 Million | 11.79 Thousand |
| Financing Cash Flow | -40.01 Million | -213.14 Million | 152.28 Million | -214.8 Million | -132.02 Million | 32.37 Million |
| Debt repayment | -13.07 Million | -142.18 Million | -262.45 Million | -15.98 Million | -92.01 Million | -625.8 Million |
| Dividends payments | -20.22 Million | -24.5 Million | -19.19 Million | -80.54 Million | -20.46 Million | -21.87 Million |
| Common Stock Repurchased | 119.58 Million | -119.58 Million | - | -100 Million | -100 Million | 100 Million |
| Common Stock Issuance | - | - | - | - | - | -100 Million |
| Other Financing Activities | -6.71 Million | 52.47 Million | -90.96 Million | -150.24 Million | -19.54 Million | 680.04 Million |
| Accounts receivables | - | -238.73 Million | - | -34.96 Million | -34.96 Million | 120.42 Million |
| Accounts payables | - | - | - | 734.65 Million | - | - |
| Inventory | - | -98.32 Million | - | -396.57 Million | -396.57 Million | 162.7 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 310.87 Million | 298.9 Million | 402.88 Million | 526.75 Million | 279.12 Million | 462.45 Million |
| Cash at end of period | 170.61 Million | 322.92 Million | 286.9 Million | 402.88 Million | 402.88 Million | 279.12 Million |
| Capital Expenditure | -76.71 Million | 11.21 Million | -18.18 Million | -104.11 Million | 30.63 Million | -23.36 Million |
| Effect of forex changes on cash | 42.02 | -7.00 | - | -7.82 | -2.12 | -4.88 Million |
| Net cash flow / Change in cash | -140.26 Million | 24.02 Million | -115.97 Million | -123.87 Million | 123.75 Million | -183.32 Million |
| Free Cash Flow | -89.65 Million | 230.91 Million | -272.85 Million | 21.64 Million | 232.26 Million | -215.71 Million |
RAJRATAN
SABSW
SANCO
REYN
TGLO
HCH